The LRRC32 gene gives cells instructions for making a surface protein that helps control an important immune signal called TGF-β, which helps keep inflammation in balance. This gene plays an important role in helping certain immune cells calm immune responses and support normal tissue repair. If the LRRC32 gene does not work properly, these signals may be less controlled, and some people may be more likely to develop immune imbalance or inflammation related problems. LRRC32 is mainly known in research and medicine rather than popular culture.
What is a gene?
A gene is a stretch of DNA that carries instructions your cells use to make molecules or regulate processes in the body. Some genes hold the instructions for producing proteins, which are the working parts of cells. Other genes mostly help determine when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can find more information in the LearnHub.
Overview
LRRC32Gene function
What if the gene works
The LRRC32 gene helps hold inactive TGF-β (a signaling protein) on certain cell surfaces, especially regulatory T cells and platelets. This supports immune balance and controlled signaling between cells.
Risk
What if the gene does not work
Milder to more severe variants in the LRRC32 gene can reduce how well cells hold and activate latent TGF-β, an immune signaling protein, especially on regulatory T cells and platelets. This can weaken signals that help keep responses in balance.
Treatment
What does that mean for your treatment
A pathogenic or loss of function variant in the LRRC32 gene does not currently have a gene specific treatment or management approach in clinical guidelines. Researchers are studying the LRRC32 gene as an immune marker and possible drug target, especially in cancer and inflammation.
Gene function
What if the gene works
Your cells use the LRRC32 gene to manage an important growth and immune signal at the cell surface. It is especially active in regulatory T cells, which help keep immune reactions measured. By controlling when this signal is held and presented, the gene supports steady communication between nearby cells.
The LRRC32 gene helps certain cells hold TGF-beta (a signaling protein) at their surface in an inactive form. This keeps the signal nearby and ready for controlled use.
Its protein presents inactive TGF-beta so partner proteins on the cell surface can switch it on when needed. This supports local, timed communication between neighboring cells.
On regulatory T cells, this system helps deliver calming signals that keep immune responses measured. This is a key part of how the LRRC32 gene works in the immune system.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. Sometimes, however, a variant changes how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the LRRC32 gene can make the GARP protein fold less reliably, reach the cell surface in lower amounts, or bind latent TGF-β less effectively. In practical terms, LRRC32 gene variants may weaken how cells present this signaling complex to nearby cells. Milder missense variants can leave some activity in place, while more disruptive splice, truncating, or deletion variants may lead to very little or no working protein.
How variants are linked to conditions
Current research on how variants in the LRRC32 gene are linked to conditions is still developing, and no single LRRC32-related condition has broad clinical agreement yet. If you have a confirmed change in the LRRC32 gene, your doctor or genetic counselor can explain what it may mean in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are common in the general population and are a normal part of human biology. Most do not have a direct effect on health and simply reflect natural human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when multiple genes and environmental factors play a role. In some cases, though, a single well-characterized variant in a specific gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LRRC32 gene. If testing has found a change in LRRC32, a doctor or genetic counselor can help explain what that result may mean for your personal and family risk.
Inheritance of LRRC32 variants
For the inheritance of the LRRC32 gene variants, there is not yet a broadly confirmed Mendelian pattern tied to a specific LRRC32-related condition. Current evidence does not support describing LRRC32 as having one well-established dominant, recessive, or X-linked inheritance pattern for disease in routine patient care. The LRRC32 gene is located on chromosome 11, which is an autosome, so each person inherits one copy from each parent.
What does my LRRC32 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific condition for LRRC32, though this understanding can change as research develops. If you have a specific LRRC32 result and questions about what it could mean for your family, a doctor or genetic counselor can explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the LRRC32 gene, LRRC32 genetic testing uses a blood, saliva, or cheek swab sample to read your DNA. A lab may sequence just this gene or include it in a larger panel, then compare your result with a reference sequence and classify any variant it finds.
When should I consider getting a genetic test?
There is not yet a broadly established, LRRC32-specific reason for genetic testing in routine care. Testing decisions are usually based on your symptoms, medical findings, and family history, with guidance from a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can provide useful insight, but what it can tell you varies with the condition and the kind of variant involved. Factors including lifestyle, environment, age, and medical history also influence how the body functions over time. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and makes the most sense when viewed with the rest of care. In other situations, a genetic result can give a clear answer. In areas like medication response, it can also help make sense of individual experiences.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in DNA can change how a drug is absorbed, broken down, or handled by the body, so the same treatment may work better for one person than for another. This is common and can influence how much benefit someone gets from a medicine or how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines the ways genetic differences can affect a person’s response to medicines. It studies links between genes and medications to help explain why the same treatment may work differently in different people. For many drugs, genes influence both how powerfully a medicine works and how the body handles it. This information can support treatment choices that are more informed and more tailored to the individual. More details on this topic are available in the LearnHub.
Drugs influenced by the LRRC32 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so side effects, trouble starting a new medicine, or questions about treatment are best discussed with your doctor or pharmacist.
History
In recent decades, awareness of the LRRC32 gene’s role in immunology has grown. It was identified during the wave of human gene mapping and sequencing studies in the late 1990s and early 2000s, when many genes with repeat-rich protein structures were first cataloged. Researchers later connected the LRRC32 gene to a cell surface protein called GARP, which brought it into studies of immune control and tolerance. From these first observations, research expanded steadily, especially in work on regulatory T cells and cancer immunology. Today, the LRRC32 gene is mainly known in research settings as part of the broader story of how the immune system is balanced and studied in modern medicine.